![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » ALDERM N.A. ANNOUNCES FDA CLEARANCE FOR THE MED SCULPT CELLULITE REDUCTION SYSTEM
ALDERM N.A. ANNOUNCES FDA CLEARANCE FOR THE MED SCULPT CELLULITE REDUCTION SYSTEM
August 9, 2006
Alderm, N.A. LLC, announced that it has received FDA clearance to market the Med Sculpt Computerized Body Massage and M-Sonic Ultrasound Diathermy system for the treatment and reduction of cellulite. Med Sculpt is a revolutionary system for non-invasive cellulite treatment. Patients have no downtime and can return to their normal activities while completing the treatment. With thousands of successful treatments in Europe over the last three years, Alderm N.A. is excited to make this technology available in the United States.
PRWeb
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct